Geneva, Switzerland, March 24, 2022 - Addex Therapeutics (SIX:ADXN and Nasdaq:ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced today that CEO, Tim Dyer, will present at both the Bio-Europe Spring 2022 Conference and the Maxim Group – 2022 Virtual Growth Conference taking place March 28 - 31, 2022 and March 28 – 30, 2022, respectively. Dr. Robert Lütjens, Head of Discovery – Biology, will also be attending the Bio-Europe event.
Read more at globenewswire.comAddex to Present at the Bio-Europe Spring 2022 and Maxim Group – 2022 Virtual Growth Conferences
Globe Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
/A%20Lucid%20Motors%20vehicle%20parked%20in%20front%20of%20a%20showroom_%20Image%20by%20Michael%20Berlfein%20via%20Shutterstock_.jpg)
/Broadcom%20Inc%20logo%20on%20phone%20and%20site-by%20Majahid%20Mottakin%20via%20Shutterstock.jpg)
/Tesla%20Inc%20logo%20by-%20baileystock%20via%20iStock.jpg)
